Isolation of precursor endothelial cells from peripheral blood for donor-specific crossmatching before organ transplantation

Transplantation

Volumn 74, Issue 11, 2002, Pages 1479-1486

  Vermehren, Dilki ^a   Sumitran Holgersson, Suchitra ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2;

ALLOTRANSPLANTATION; ANALYTIC METHOD; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; CROSS REACTION; ENDOTHELIUM CELL; HLA SYSTEM; HUMAN; HUMAN CELL; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; ORGAN TRANSPLANTATION; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANTIBODIES; BIOLOGICAL MARKERS; BLOOD CELLS; CELL SEPARATION; ENDOTHELIUM, VASCULAR; FLOW CYTOMETRY; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOHISTOCHEMISTRY; MONOCYTES; NEOPLASM PROTEINS; ORGAN TRANSPLANTATION; PROTO-ONCOGENE PROTEINS; RECEPTOR, TIE-2; RETROSPECTIVE STUDIES; STEM CELLS; TISSUE DONORS;

EID: 0037115124     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200212150-00001     Document Type: Article

References (28)

1. Kissmeyer-Nielsen F, Olsen S, Posborg-Petersen V, et al. Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells. Lancet 1966; 2: 662.
2. Ting A. Positive crossmatches: When is it safe to transplant? Transpl Int 1989; 2: 2.
3. Sumitran-Karuppan S. The clinical importance of choosing the right assay for detection of HLA-specific donor-reactive antibodies. Transplantation 1999; 68: 502.
4. Chapman JR, Taylor CJ, Ting A, et al. Immunoglobulin class and specificity of antibodies causing positive T cell crossmatches, Relationship to renal transplant outcome. Transplantation 1989; 42: 608.
5. Brasile L, Rodman E, Shield CFd, et al. The association of antivascular endothelial cell antibody with hyperacute rejection: A case report. Surgery 1986; 99: 637.
6. Sumitran-Karuppan S, Tyden G, Reinholt F, et al. Hyperacute rejections of two consecutive renal allografts and early loss of the third transplant caused by non-HLA antibodies specific for endothelial cells. Transplant Immunol 1997; 5: 321.
7. Cerilli J, Brasile L. Endothelial cell alloantigens. Transplant Proc 1980; 12(3 Suppl 1): 37.
8. Stastny P. Endothelial-monocyte antigens. Transplant Proc 1980; 12(3 Suppl 1): 32.
9. Pierce JC, Waller M, Phibbs M. A mixed antiglobulin test with kidney cells in suspension for IgG antibody in human allograft recipients. Transplantation 1975; 19: 343.
10. Wilson CB. Individual and strain differences in renal basement membrane antigens. Transplant Proc 1980; 12(3 Suppl 1): 69.
11. Paul LC, Carpenter CB. Antibodies against renal endothelial alloantigens. Transplant Proc 1980; 12(3 Suppl 1): 43.
12. Mohanakumar T, Waldrep JC, Phibbs M, et al. Serological characterization of antibodies eluted from chronically rejected human renal allografts. Transplantation 1981; 32: 61.
13. Hosenpud JD, Everett JP, Morris TE, et al. Cardiac allograft vasculopathy. Association with cell-mediated but not humoral alloimmunity to donor-specific vascular endothelium. Circulation 1995; 92: 205.
14. Perrey C, Brenchley PE, Johnson RW, et al. An association between antibodies specific for endothelial cells and renal transplant failure. Transplant Immunol 1998; 6: 101.
15. Kalil J, Guilherme L, Neumann J, et al. Humoral rejection in two HLA identical living related donor kidney transplants. Transplant Proc 1989; 21(1 Pt 1): 711.
16. Sumitran-Holgersson S, Wilczeck H, Holgersson J et al. Identification of the non-classical HLA molecules, MICA, as targets for humoral immunity associated with irreversible rejections of kidney allografts. Transplantation 2002; 74: 268.
17. Cerilli J, Bay W, Brasile L. The significance of the monocyte crossmatch in recipients of living-related HLA identical kidney graft. Hum Immunol 1983; 7: 45.
18. Ianhez L, Saldanha LB, Paula FJ, et al. Humoral rejection with negative crossmatches. Transplant Proc 1989; 21: 720.
19. Asahara T, Murohara T, Sullivan A. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964.
20. Peichev M, Naiyer AJ, Pereira D, et al. Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors. Blood 2000; 95: 952.
21. Vartdal F, Gaudernack G, Funderud S, et al. HLA class I and II typing using cells positively selected from blood by immunomagnetic isolation: A fast and reliable technique. Tissue Antigens 1986; 28: 301.
22. Sumitran-Karuppan S, Lindholm A, Möller E. Fewer acute rejection episodes and improved outcome in kidney transplanted patients with changed selection of criteria based on cross-matching? Transplantation 1992; 53: 666.
23. Sumitran-Karuppan S, Moller E. Specific inhibition of HLA class I and II antibodies by soluble antigens: A method for the identification of antibody specificity in sera from alloimmunized individuals. Transplantation 1994; 58: 713.
24. Sumitran-Karuppan S, Moller E. The use of magnetic beads coated with soluble HLA class I or class II proteins in antibody screening and for specificity determinations of donor-reactive antibodies. Transplantation 1996; 61: 1539.
25. Moraes JR, Moraes ME, Luo Y, et al. Alloantibodies against donor epidermis and early kidney transplant rejection. Transplantation 1991; 51: 370.
26. Schnurch H, Risau W. Expression of Tie-2, a member of a novel family of receptor tyrosine kinases, in the endothelial cell lineage. Development 1993; 119: 957.
27. Woolf AS, Yuan HT. Angiopoietin growth factors and Tie receptor tyrosine kinases in renal vascular development. Pediatr Nephrol 2001; 16: 177.
28. Sumitran-Holgersson S, Hogersson J. Phenotypic and Functional Characterization of Endothelial Cell Precursors. (in press).